Liver cancer treatment has changed a lot in five years, and how it changed tells you a lot about where it’s going. Most of ...

A new review proposes that the ratio of monounsaturated to polyunsaturated membrane phospholipids acts as a tunable rheostat ...

The FDA approved a new targeted therapy called Lyrfigtu (lirafugratinib) on September 23, 2026, for a specific type of bile ...

Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often ...

Bile duct cancer is medically known as Cholangiocarcinoma. It refers to cancers that arise in the intrahepatic, perihilar, or distal biliary tree. Although it accounts for only about 3% of ...

Researchers in South Korea have developed a fully automated deep-learning system that uses supervised contrastive learning across multiphase CT scans to distinguish cholangiocarcinoma from benign ...

A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose type of radiation delivery may significantly improve outcomes for patients ...

(Boston)—Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is ...

A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose type of radiation delivery may significantly improve outcomes for patients ...

Cholangiocarcinomas are malignant tumors that derive from cholangiocytes of small intrahepatic bile ducts or bile ductules (intrahepatic cholangiocarcinoma; ICC), or of large hilar or extrahepatic ...

2-Apr-2026 at 12:05 AM EDT, by The University of Texas MD Anderson Cancer Center contact patient services Testing did not find significant biological differences between very large tumors and smaller ...